Christa Pike, a 50‑year‑old death‑row inmate in Tennessee, was found unconscious, intubated and on a ventilator on Thursday night after authorities attempted to execute her with lethal injection.
Background
Pike was sentenced to death in 1996 for the 1995 murder of 19‑year‑old Colleen Slemmer. She is the only woman on Tennessee’s death row.
What Went Wrong
According to court filings from Pike’s lawyers, two lethal doses of pentobarbital were administered on Wednesday, yet Pike remained alive. The filings describe a series of procedural problems:
- At least seven needles were used to start intravenous (IV) lines, with one needle bent at a 90‑degree angle when removed.
- Lawyers claim the execution team did not realize that the IV lines were improperly placed or that the veins had collapsed.
- During the injection, Pike could be heard "crying, whimpering, and breathing loudly" throughout the procedure.
Dr. Joel Zivot, an anesthesiologist for the defense, testified that the pentobarbital likely never reached a high enough blood level to cause death, suggesting the drug may have spread under the skin rather than entering the bloodstream. He also noted that blisters on Pike’s arm indicated a ruptured vein, and that her condition of thrombocytosis could have formed clots that blocked the drug.
Legal and Political Fallout
Following the botched execution, Pike’s lawyers filed an emergency motion to preserve all evidence related to the attempt. Tennessee Governor Bill Lee ordered an independent review and halted all executions in the state for the year. The state’s Department of Correction defended its protocol, stating it did not allow for additional procedures beyond what was carried out.
Analysis
The failure appears linked to IV access problems. Multiple needle attempts, a bent needle, and possible vein collapse suggest that the drug may not have been delivered intravenously as intended. Without proper IV placement, the lethal dose cannot achieve the rapid systemic effect required for execution.
Additionally, Pike’s medical condition—thrombocytosis—could have exacerbated the difficulty of establishing reliable IV access, increasing the risk of clot formation at the injection site.
Uncertainty
While the filings provide a detailed account of the IV complications, the exact cause of the drug’s ineffective delivery remains unconfirmed. Authorities have not publicly explained why the execution failed, and it is unclear whether drug quality, storage issues, or other procedural factors contributed.
Furthermore, the state has not indicated whether a second execution attempt will be made, leaving the future of Pike’s sentence uncertain.
